Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chantal Mathieu

Showing results (321-330 of 626) with videos related to

Pageof 63
Sort By:
BMJ Open|November 29, 2024
Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trialJulie Wych, Martina Brunner, Rachel Stenson, et al.
Diabetes Technology & Therapeutics|March 29, 2021
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World StudyAstrid Lavens, Frank Nobels, Christophe De Block, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 22, 2024
The effect of physical activity on glycaemic control in people with type 1 diabetes mellitus: A systematic literature review and meta-analysisDiederik De Cock, Lucas Schreurs, Nele Steenackers, et al.
Diabetes Technology & Therapeutics|July 31, 2025
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring-Based Hypoglycemia, Including Duration, in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6Thomas Danne, Susanne Engberg, Concetta Irace, et al.
Lancet (London, England)|June 26, 2023
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialJuan P Frias, Srikanth Deenadayalan, Lars Erichsen, et al.
Diabetes|January 29, 2008
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathwaysZeynep Dogusan, Mónica García, Daisy Flamez, et al.
Arthritis and Rheumatism|August 1, 2007
Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathyMuhammad S Soyfoo, Carine De Vriese, Huguette Debaix, et al.
Diabetes|July 28, 2005
Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cellsConny A Gysemans, Laurence Ladrière, Hanne Callewaert, et al.
Annals of Internal Medicine|January 18, 2012
High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trialAn Lehouck, Chantal Mathieu, Claudia Carremans, et al.
Diabetes, Obesity & Metabolism|September 15, 2022
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetesAthena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, et al.
Pageof 63

Showing results (321-330 of 626) with videos related to

Sort By:
Pageof 63
BMJ Open|November 29, 2024
Investigating the effect of verapamil on preservation of beta-cell function in adults with newly diagnosed type 1 diabetes mellitus (Ver-A-T1D): protocol for a randomised, double-blind, placebo-controlled, parallel-group, multicentre trialJulie Wych, Martina Brunner, Rachel Stenson, et al.
Diabetes Technology & Therapeutics|March 29, 2021
Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World StudyAstrid Lavens, Frank Nobels, Christophe De Block, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 22, 2024
The effect of physical activity on glycaemic control in people with type 1 diabetes mellitus: A systematic literature review and meta-analysisDiederik De Cock, Lucas Schreurs, Nele Steenackers, et al.
Diabetes Technology & Therapeutics|July 31, 2025
Continuous Glucose Monitoring Metrics and Continuous Glucose Monitoring-Based Hypoglycemia, Including Duration, in Individuals with Type 1 Diabetes Switching to Once-Weekly Insulin Icodec: A Post Hoc Evaluation of ONWARDS 6Thomas Danne, Susanne Engberg, Concetta Irace, et al.
Lancet (London, England)|June 26, 2023
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialJuan P Frias, Srikanth Deenadayalan, Lars Erichsen, et al.
Diabetes|January 29, 2008
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of the toll-like receptor 3 and interferon regulatory factor 3 pathwaysZeynep Dogusan, Mónica García, Daisy Flamez, et al.
Arthritis and Rheumatism|August 1, 2007
Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathyMuhammad S Soyfoo, Carine De Vriese, Huguette Debaix, et al.
Diabetes|July 28, 2005
Disruption of the gamma-interferon signaling pathway at the level of signal transducer and activator of transcription-1 prevents immune destruction of beta-cellsConny A Gysemans, Laurence Ladrière, Hanne Callewaert, et al.
Annals of Internal Medicine|January 18, 2012
High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trialAn Lehouck, Chantal Mathieu, Claudia Carremans, et al.
Diabetes, Obesity & Metabolism|September 15, 2022
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetesAthena Philis-Tsimikas, Harpreet S Bajaj, Kamilla Begtrup, et al.
Pageof 63